Chemically-enhanced primer compositions, methods and kits

Patent metadata

Field	Value
Publication number	US-12006536-B2
Application number	US-202117399449-A
Country	US
Kind code	B2
Filing date	Aug 11, 2021
Priority date	Oct 28, 2010
Publication date	Jun 11, 2024
Grant date	Jun 11, 2024

Abstract

A chemically-enhanced primer is provided comprising a negatively charged moiety (NCM), an oligonucleotide sequence having a) non-nuclease resistant inter-nucleotide linkages or b) at least one nuclease resistance inter-nucleotide linkage. The chemically-enhanced primer can be used for sequencing and fragment analysis. Methods for synthesizing the chemically-enhanced primer as well as a method of preparing DNA for sequencing, a method of sequencing DNA, and kits containing the chemically-enhanced primer are also provided. The method of sequencing DNA can comprise contacting amplification reaction products with the composition wherein excess amplification primer is degraded by the nuclease and the chemically-enhanced primer is essentially non-degraded.

First claim

What is claimed is:

1. A chemically-enhanced primer, comprising:
a negatively charged moiety (NCM) disposed at a 5′ end of the chemically-enhanced primer, the NCM having a branched arrangement.

2. A composition for sequencing nucleic acid, comprising:
the chemically-enhanced primer according to claim 1 .

3. The composition of claim 2 , wherein
the chemically-enhanced primer further comprises an oligonucleotide sequence having a) non-nuclease resistant inter-nucleotide linkages or b) at least one nuclease resistance inter-nucleotide linkage, and
the oligonucleotide sequence of the chemically-enhanced primer comprises a universal primer.

4. The composition of claim 3 wherein the universal primer is selected from M13, US1, T7, SP6, and T3.

5. The chemically-enhanced primer of claim 1 , further comprising:
an oligonucleotide sequence having a) non-nuclease resistant inter-nucleotide linkages or b) at least one nuclease resistance inter-nucleotide linkage,
wherein the at least one nuclease resistant inter-nucleotide linkage comprises a phosphorothioated linkage.

6. The chemically-enhanced primer of claim 5 , wherein the phosphorothioated linkage is disposed at a 3′ end of the chemically-enhanced primer.

7. The chemically-enhanced primer of claim 1 , wherein the NCM comprises a moiety having a structure of the following formula:

wherein each n is independently an integer of 1 to 9, and x is an integer of 1 to about 30.

8. The chemically-enhanced primer of claim 1 , wherein the NCM has the branched arrangement as a doubler or trebler.

9. The chemically-enhanced primer of claim 1 , wherein each branch of the NCM includes a series of connected alkyl phosphate mono-mers having formula (C n ) x , wherein n is 1-9 and x is at least 5.

10. The chemically-enhanced primer of claim 1 , further comprises:
an oligonucleotide sequence having at least one phosphorothioated inter-nucleotide linkage, wherein the at least one phosphorothioated inter-nucleotide linkage is disposed at a 3′ end of the chemically-enhanced primer.

11. The composition of claim 2 , wherein
the chemically-enhanced primer further comprises an oligonucleotide sequence, and
the oligonucleotide sequence of the chemically-enhanced primer comprises a universal primer.

12. The composition of claim 11 , wherein the universal primer is selected from M13, US1, T7, SP6, and T3.

13. The composition of claim 2 , further comprising: a polymerase, a nuclease, a deoxynucleotide triphosphates, dideoxynucleotide triphosphates and a dye-label.

14. The composition of claim 13 , wherein the dideoxynucleotide triphosphates comprise dye-labeled dideoxynucleotide triphosphates.

15. The composition of claim 14 , wherein the dye-labeled dideoxynucleotide triphosphates comprise fluorescent dye-labeled dideoxynucleotide triphosphates.

16. The composition of claim 13 , wherein the dye-label is attached to the NCM.

17. The composition of claim 13 , wherein the nuclease is selected from exonuclease I, Exo III, Pfu and DNA pol I.

18. The composition of claim 13 , further comprising: a PCR amplification reaction product that comprises non-nuclease-resistant amplification primer(s).

19. The composition of claim 18 , wherein the PCR amplification reaction product further comprises an amplified DNA target sequence.

20. The composition of claim 13 , wherein the polymerase is Taq polymerase.

21. The composition of claim 13 , wherein the dye-label is attached to the NCM or the oligonucleotide sequence.

Assignees

• Life Technologies Corp

Inventors

• Lee Linda
• Woo Sam
• Ma Peter

Classifications

• C12Q2525/125

  incorporating agents resulting in resistance to degradation · CPC title

• C12Q2525/113

  incorporating modified backbone · CPC title

• C12Q1/6869 Primary

  Methods for sequencing · CPC title

• C12Q1/6853

  using modified primers or templates · CPC title

• C12Q1/6874 Primary

  involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title